Perindopril
Research News and Information

Monday, November 23, 2009

Long-term effects of perindopril on left ventricular structure and function in patients with stable coronary artery disease: a conventional and Doppler tissue echocardiographic pilot study.

29 Sep 2009 OBJECTIVES: The aim of this study was to investigate the long-term effects of perindopril on left ventricular (LV) systolic and diastolic function in patients with stable coronary artery disease who had previously undergone coronary artery bypass ... Read more...

Baseline heart rate, antihypertensive treatment, and prevention of cardiovascular outcomes in ASCOT (Anglo-Scandinavian Cardiac Outcomes Trial).

20 Sep 2009 OBJECTIVES: The aim of this study was to evaluate the effect of baseline heart rate on the efficacy of atenolol-based compared with amlodipine-based therapy in patients with hypertension uncomplicated by coronary heart disease in the ASCOT-BPLA ... Read more...

Coronary calcium significantly affects quantitative analysis of coronary ultrasound: importance for atherosclerosis progression/regression studies.

30 Aug 2009 BACKGROUND: Coronary atherosclerosis is a dynamic process, which progresses differently in coronary segments containing noncalcified or calcified plaques. This may have implications for the study of the effects of therapy on progression/regression. ... Read more...

Latest indexed articles for 'Perindopril'

These are the very latest articles for this heading:

• Long-term effects of perindopril on left ventricular structure and function in patients with stable coronary artery disease: a conventional and Doppler tissue echocardiographic pilot study. 29 Sep 2009
• Baseline heart rate, antihypertensive treatment, and prevention of cardiovascular outcomes in ASCOT (Anglo-Scandinavian Cardiac Outcomes Trial). 20 Sep 2009
• Coronary calcium significantly affects quantitative analysis of coronary ultrasound: importance for atherosclerosis progression/regression studies. 30 Aug 2009
• Understanding heart failure with preserved ejection fraction: clinical importance and future outlook. 29 Jun 2009
• Effects of ARB or ACE-inhibitor administration on plasma levels of aldosterone and adiponectin in hypertension. 29 Jun 2009
• The effects of perindopril on aortic elasticity and inflammatory markers in hypertensive patients. 29 Jun 2009
• Perindopril decreases P wave dispersion in patients with stage 1 hypertension. 30 May 2009
• Comparison of the effects of antihypertensive agents on central blood pressure and arterial stiffness in isolated systolic hypertension. 30 May 2009
• Combination of vitamin K2 and angiotensin-converting enzyme inhibitor ameliorates cumulative recurrence of hepatocellular carcinoma. 13 May 2009
• Blood pressure and glucose control in subjects with diabetes: new analyses from ADVANCE. 29 Apr 2009
• Consistency of treatment effect of perindopril and indapamide across broad spectrum of vascular disease. 29 Apr 2009
• Heart protection: a key target in the management of patients with diabetes. 29 Apr 2009
• Protection of patients with diabetes, with or without hypertension: implications of ADVANCE for clinical practice. 29 Apr 2009
• Successful revascularisation of a thrombosed renal artery aneurysm in a young man with solitary kidney and history of severe hypertension. 29 Apr 2009
• Effects of perindopril on cardiac remodelling and prognostic value of pre-discharge quantitative echocardiographic parameters in elderly patients after acute myocardial infarction: the PREAMI echo sub-study. 28 Apr 2009
• Decreased muscle ACE activity enhances functional response to endurance training in rats, without change in muscle oxidative capacity or contractile phenotype. 28 Apr 2009
• Long term monitoring in patients receiving treatment to lower blood pressure: analysis of data from placebo controlled randomised controlled trial. 28 Apr 2009
• Severe cerebral white matter hyperintensities predict severe cognitive decline in patients with cerebrovascular disease history. 21 Apr 2009
• A case of Parkinson's disease worsened by captopril: an unexpected adverse effect. 13 Apr 2009
• Effects of the end point adjudication process on the results of the Perindopril Protection Against Recurrent Stroke Study (PROGRESS). 7 Apr 2009

See a longer list of these articles.

Technical information about 'Perindopril'

Definition: An angiotensin-converting enzyme inhibitor. It is used in patients with hypertension and heart failure.

Chemical name: 1H-Indole-2-carboxylic acid, 1-(2-((1-(ethoxycarbonyl)butyl)amino)-1-oxopropyl)octahydro-

Registry Number: 82834-16-0

Descriptor UI: D020913

Alternative terms: Perindopril; Pirindopril; Perstarium; S-9490; S 9490; S9490; S 9490-3; S 9490 3; S 94903; Perindopril Erbumine; Erbumine, Perindopril;

Allowable Qualifiers: administration & dosage; adverse effects; analogs & derivatives; analysis; antagonists & inhibitors; blood; cerebrospinal fluid; chemical synthesis; classification; diagnostic use; economics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; poisoning; radiation effects; standards; supply & distribution; therapeutic use; toxicity; urine; chemistry; contraindications; agonists;

Pharmacological Action: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents;

Tree Number: D03.438.473.766;

History Note: 2000; use PERINDOPRIL (NM) 1985-1999